TY - JOUR
T1 - Availability of resources to apply the 2024 McDonald criteria
T2 - A global perspective
AU - Gómez-Salazar, Natalia
AU - Ortíz-Salas, Paola A.
AU - Wicklein, Rebecca
AU - Yam, Charmaine
AU - Avilés-Gómez, Mateo
AU - Casas, Magdalena
AU - Cauchi, Marija
AU - D’Alessandro, Sofía
AU - Galimberti, Michela
AU - Gklinos, Panagiotis
AU - Maldonado-Higuera, Fernando
AU - Navas-Peñaranda, Suhamny
AU - Ongphichetmetha, Tatchaporn
AU - Pelaez-Suarez, Alejandro A.
AU - Polo-Orcasitas, Wilson A.
AU - de Queiroz, André L.Guimarães
AU - Reynolds, Audrey
AU - Sattarnezhad, Neda
AU - Tena-Cucala, Raquel
AU - Vladacenco, Oana
AU - Barbosa-Rengifo, Mario M.
AU - Brownlee, Wallace
AU - Tintoré, Mar
N1 - Publisher Copyright:
© The Author(s), 2026. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
PY - 2026
Y1 - 2026
N2 - Background: The 3rd ECTRIMS Winter School highlighted regional and global disparities in resources needed to implement the 2024 McDonald diagnostic criteria for multiple sclerosis. Objectives: To assess the availability of paraclinical tools and regional differences in access reported by neurologists in an online survey. Results: The survey was completed by 328 neurologists from 44 countries. Core diagnostic tools, including magnetic resonance imaging and oligoclonal band testing, were widely available. Access to advanced imaging, optic nerve assessment, and laboratory biomarkers varied across regions. Conclusions: Variability in access to key paraclinical tests may impact on the implementation of the 2024 McDonald criteria globally.
AB - Background: The 3rd ECTRIMS Winter School highlighted regional and global disparities in resources needed to implement the 2024 McDonald diagnostic criteria for multiple sclerosis. Objectives: To assess the availability of paraclinical tools and regional differences in access reported by neurologists in an online survey. Results: The survey was completed by 328 neurologists from 44 countries. Core diagnostic tools, including magnetic resonance imaging and oligoclonal band testing, were widely available. Access to advanced imaging, optic nerve assessment, and laboratory biomarkers varied across regions. Conclusions: Variability in access to key paraclinical tests may impact on the implementation of the 2024 McDonald criteria globally.
KW - diagnostic techniques
KW - epidemiology
KW - health services accessibility
KW - multiple sclerosis
KW - neurological
UR - https://www.scopus.com/pages/publications/105054302201
U2 - 10.1177/13524585261493315
DO - 10.1177/13524585261493315
M3 - Article
AN - SCOPUS:105054302201
SN - 1352-4585
JO - Multiple Sclerosis Journal
JF - Multiple Sclerosis Journal
ER -